Hancock Whitney Corp Has $28.19 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hancock Whitney Corp boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 54,015 shares of the medical equipment provider's stock after purchasing an additional 950 shares during the quarter. Intuitive Surgical comprises 0.9% of Hancock Whitney Corp's holdings, making the stock its 19th biggest position. Hancock Whitney Corp's holdings in Intuitive Surgical were worth $28,194,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of ISRG. Howard Capital Management Group LLC raised its position in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider's stock valued at $1,044,000 after acquiring an additional 92 shares during the period. Principal Financial Group Inc. raised its holdings in Intuitive Surgical by 1.5% in the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider's stock worth $295,938,000 after purchasing an additional 9,194 shares during the period. World Investment Advisors LLC bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at $228,000. Arvest Bank Trust Division bought a new position in Intuitive Surgical during the third quarter worth about $260,000. Finally, Wilmington Savings Fund Society FSB grew its stake in Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock valued at $272,980,000 after acquiring an additional 552,058 shares during the period. Institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 30,819 shares of company stock valued at $15,937,836. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on ISRG shares. Wells Fargo & Company raised their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Barclays cut their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Evercore ISI lowered their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. Truist Financial cut their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Finally, Raymond James increased their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $598.95.

Intuitive Surgical Stock Down 0.1 %

Shares of NASDAQ:ISRG traded down $0.73 during midday trading on Tuesday, hitting $513.29. The stock had a trading volume of 489,846 shares, compared to its average volume of 1,611,698. The business's 50-day simple moving average is $510.03 and its 200-day simple moving average is $533.26. Intuitive Surgical, Inc. has a 12 month low of $367.39 and a 12 month high of $616.00. The company has a market cap of $182.82 billion, a P/E ratio of 80.10, a PEG ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the prior year, the company posted $1.50 earnings per share. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.